- Home
- PSTL vs HUMA Comparison
PSTL vs HUMA Comparison
Compare PSTL & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSTL
- HUMA
- Stock Information
- Founded
- PSTL 2018
- HUMA 2004
- Country
- PSTL United States
- HUMA United States
- Employees
- PSTL N/A
- HUMA N/A
- Industry
- PSTL Real Estate Investment Trusts
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- PSTL Real Estate
- HUMA Health Care
- Exchange
- PSTL Nasdaq
- HUMA Nasdaq
- Market Cap
- PSTL 329.8M
- HUMA 250.2M
- IPO Year
- PSTL 2019
- HUMA N/A
- Fundamental
- Price
- PSTL $15.84
- HUMA $1.51
- Analyst Decision
- PSTL Strong Buy
- HUMA Strong Buy
- Analyst Count
- PSTL 1
- HUMA 8
- Target Price
- PSTL $17.75
- HUMA $10.88
- AVG Volume (30 Days)
- PSTL 149.9K
- HUMA 5.9M
- Earning Date
- PSTL 08-04-2025
- HUMA 08-11-2025
- Dividend Yield
- PSTL 6.12%
- HUMA N/A
- EPS Growth
- PSTL 344.13
- HUMA N/A
- EPS
- PSTL 0.39
- HUMA N/A
- Revenue
- PSTL $86,535,000.00
- HUMA $818,000.00
- Revenue This Year
- PSTL $22.00
- HUMA N/A
- Revenue Next Year
- PSTL $9.76
- HUMA $949.92
- P/E Ratio
- PSTL $40.92
- HUMA N/A
- Revenue Growth
- PSTL 26.43
- HUMA N/A
- 52 Week Low
- PSTL $12.26
- HUMA $1.15
- 52 Week High
- PSTL $15.84
- HUMA $6.77
- Technical
- Relative Strength Index (RSI)
- PSTL 70.89
- HUMA 36.87
- Support Level
- PSTL $15.31
- HUMA $1.43
- Resistance Level
- PSTL $15.55
- HUMA $1.67
- Average True Range (ATR)
- PSTL 0.24
- HUMA 0.15
- MACD
- PSTL 0.11
- HUMA -0.01
- Stochastic Oscillator
- PSTL 100.00
- HUMA 23.32
About PSTL Postal Realty Trust Inc.
Postal Realty Trust Inc is an internally managed real estate corporation that owns and manages properties leased to the United States Postal Service, or the USPS. Its objective is to create stockholder value by generating risk-adjusted returns through expanding its portfolio of owned and managed postal properties leased to the USPS. The majority of the revenue is generated from the rental income received.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.